Cantel Medical competitors

José E. Almeida is a Brazilian businessman. He has served as the chairman and CEO of Baxter International, Inc. since January 2016. He worked for Tyco Healthcare from 1995 to 2002. He was president of Medical Devices division from October 2006 to June 2011. He served as chairman of the board of directors of Covidien since March 2012 and as the president, chief executive officer and a director since July 2011. He became a director of EMC Corporation on Jan 12, 2015 and resigned on October 30, 2015, due to his election as chairman and CEO of Baxter. In 2015, he worked for The Carlyle Group as an Operating Executive in the Global Healthcare group.

Michael A. Mussallem, age 56, has been chairman and CEO of Edwards Lifesciences, Inc. since 2000. Prior to 2000, Mussallem held a variety of positions with increasing responsibility in engineering, product development and senior management at Baxter International Inc., including Group Vice President of its CardioVascular business from 1994 to 2000 and Group Vice President of the Biopharmaceutical business from 1998 to 2000. From 1996 until 1998, he was the Chairman of Baxter's Asia Board overseeing Baxter's operations throughout Asia. Mr. Mussallem is chairman of the board of directors of the Advanced Medical Technology Association (AdvaMed), and serves as a member of the board for Advanced Medical Optics. He is also on the boards and executive committees of the California Healthcare Institute and OCTANe, and is a trustee of the University of California, Irvine Foundation. He received a bachelor's degree in chemical engineering in 1974 and an honorary doctorate in 1999 from the Rose-Hulman Institute of Technology in Indiana.

Vivek Jain is a President at CAREFUSION CORP, Board Member at Envista Holdings Corporation, and Chairman/CEO at ICU MEDICAL INC/DE. He has worked as Pres:Medical Tech & Services at CAREFUSION CORP, Pres:Procedural Solutions at CAREFUSION CORP, and Mng Dir/Investment Banker at JPMorgan Chase & Co. Vivek studied at University of Chicago.

Ed was named president & chief executive officer of Owens & Minor, effective March 7, 2019, and was appointed to the board of directors at the same time. Prior to that, Ed served as an independent consultant and advisor in the healthcare, life science and distribution industries since January 2016. From January 2000 through April 2015, he served in various roles of increasing responsibility at Thermo Fisher Scientific, a $17 billion manufacturer and supplier of a range of products to the research, healthcare, industrial and safety markets, including most recently as chief commercial officer & senior vice president. Before joining Thermo Fisher Scientific, Ed spent eight years at TRW Inc., in a variety of finance roles and three years with PricewaterhouseCoopers as an auditor.

Kevin serves as the fifth Chairman and CEO at Stryker since it was founded in 1941 by Dr. Homer Stryker, an orthopaedic surgeon. Stryker is a leading medical technology company with over 40,000 employees. Kevin was born in India, grew up in Canada, and has lived and worked in four countries and four industries. He is the current chair of AdvaMed (Med-Tech trade association) and is a member of the Business Roundtable and Business Council. He is also active with community boards.

Rainer Blair is the President and Chief Executive Officer of Danaher Corporation. Beginning September 2020, Rainer has led Danaher’s $21B global, multi-industry portfolio of businesses. With the help of Danaher’s 67,000 global associates, he is focused on further strengthening Danaher’s position as a leading science and technology company. Rainer is a dedicated leader and practitioner of the Danaher Business System, the company’s pre-eminent operating model and cultural foundation. He is deeply committed to the company’s Core Values and Shared Purpose: Helping Realize Life’s Potential. He has been a principle architect of Danaher’s associate engagement strategy and Diversity + Inclusion journey.